S. Kakolyris

发表

Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2002, International journal of radiation oncology, biology, physics.

Evaluation of artificial time series microarray data for dynamic gene regulatory network inference.

I. Seimenis, A. Adamopoulos, S. Kakolyris, 2017, Journal of theoretical biology.

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse

D. Mavroudis, V. Georgoulias, M. Perraki, 2004, International journal of cancer.

Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.

S. Agelaki, V. Georgoulias, N. Athanasiadis, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan (CPT-11) in Combination With Infusional 5-Fluorouracil and Leucovorin (de Gramont Regimen) as First-Line Treatment in Patients With Advanced Colorectal Cancer: A Multicenter Phase II Study

V. Georgoulias, N. Ziras, D. Mavroudis, 2002, American journal of clinical oncology.

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.

S. Agelaki, V. Georgoulias, N. Vardakis, 2001, Lung cancer.

Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma

T. Powles, M. Dowsett, A. Harris, 1999, Cancer.

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.

V. Georgoulias, J. Souglakos, P. Papakostas, 2001, European journal of cancer.

Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial

V. Georgoulias, G. Samonis, A. Rapti, 1999 .

Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.

V. Georgoulias, E. Tsaroucha, C. Kouroussis, 2006, Lung cancer.

Oxaliplatin (L-OHP) combined with irinotecan (CPT-11), leucovorin (LV) and fluorouracil (5-FU) compared with irinotecan, leucovorin and fluorouracil as first-line treatment for metastatic colorectal cancer (MCC): Preliminary results of a multicenter randomized phase III trial.

N. Ziras, J. Souglakos, A. Polyzos, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.

M. Dimopoulos, V. Georgoulias, G. Samonis, 2000, American journal of clinical oncology.

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

R. Crevoisier, J. Bourhis, V. Georgoulias, 2001 .

Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.

M. Dimopoulos, V. Georgoulias, C. Papadimitriou, 1997, Seminars in oncology.

Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas

A. Harris, K. Gatter, H. Turley, 2004, Angiogenesis.

Plasminogen activator inhibitor‐1 as a measure of vascular remodelling in breast cancer

A. Harris, K. Gatter, J. Grøndahl‐Hansen, 2001, The Journal of pathology.

Front-Line T reatment o f A dvanced N on-Small-Cell Lung C ancer W ith D ocetaxel a nd G emcitabine: A M ulticenter P hase I I T rial

M. Dimopoulos, V. Georgoulias, C. Papadimitriou, 1999 .

Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.

V. Georgoulias, G. Samonis, D. Mavroudis, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TGF-β induced epithelial-mesenchymal transition modeling

I. Seimenis, A. Adamopoulos, S. Kakolyris, 2015 .

A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.

S. Agelaki, V. Georgoulias, D. Mavroudis, 2001, Lung cancer.

A Dose‐Finding Study of the Weekly Administration of Paclitaxel in Patients With Advanced Solid Tumors

D. Mavroudis, V. Georgoulias, G. Samonis, 2001, American journal of clinical oncology.

Outcome of lung cancer patients admitted to the intensive care unit with acute respiratory failure.

N. Barbetakis, C. Asteriou, S. Kakolyris, 2013, Hippokratia.

Phase I study of weekly Docetaxel (D) and Gemcitabine (G) in advanced non-small cell lung cancer

V. Georgoulias, G. Samonis, D. Mavroudis, 2000 .

Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer.

V. Georgoulias, G. Samonis, L. Vamvakas, 1998, American journal of clinical oncology.

Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG).

V. Georgoulias, N. Ziras, J. Souglakos, 2010, Critical reviews in oncology/hematology.

Three versus six months adjuvant FOLFOX or CAPOX for high risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.

V. Georgoulias, I. Boukovinas, N. Ziras, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

V. Georgoulias, G. Samonis, E. Papadakis, 1997 .

Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.

S. Agelaki, V. Georgoulias, G. Samonis, 2000, Seminars in oncology.

Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

V. Georgoulias, I. Boukovinas, J. Souglakos, 2014, BMC Cancer.

Pooled Analysis of Elderly Patients with Non-small Cell Lung Cancer Treated with Front Line Docetaxel/Gemcitabine Regimen: The Hellenic Oncology Research Group Experience

S. Agelaki, V. Georgoulias, I. Boukovinas, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.

A. Harris, V. Georgoulias, K. Gatter, 2000, Cancer research.

Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.

M. Dimopoulos, V. Georgoulias, G. Aravantinos, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First‐line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine

G. Chalkiadakis, G. Samonis, J. Souglakos, 1998, Cancer.

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First line treatment with docetaxel (D) and gemcitabine (G) in patients with inoperable pancreatic cancer: a multicenter phase II study

G. Fountzilas, D. Mavroudis, N. Tsavaris, 1999 .

Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas

M. Tzardi, M. Vlychou, V. Gorgoulis, 1999, Medical oncology.

Treatment of non-small-cell lung cancer with prolonged oral etoposide.

S. Agelaki, V. Georgoulias, G. Chalkiadakis, 1998, American journal of clinical oncology.

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.

V. Georgoulias, C. Papadimitriou, S. Kakolyris, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 1998, European journal of cancer.

Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes

S. Agelaki, V. Georgoulias, K. Stylianou, 2001, British Journal of Cancer.

Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.

K. Gatter, I. Hickson, A. Giatromanolaki, 2001, International journal of radiation oncology, biology, physics.

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.

M. Dimopoulos, V. Georgoulias, C. Papadimitriou, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.